SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001567619-20-012996
Filing Date
2020-07-07
Accepted
2020-07-07 16:45:05
Documents
1
Period of Report
2020-07-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 4033
  Complete submission text file 0001567619-20-012996.txt   5473
Mailing Address C/O AUDENTES THERAPEUTICS, INC. 600 CALIFORNIA ST., 17TH FLOOR SAN FRANCISCO CA 94108
Business Address
Soloway Thomas P (Reporting) CIK: 0001454280 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39041 | Film No.: 201016472

Mailing Address 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 64080
Business Address 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 64080 415-505-0809
Satsuma Pharmaceuticals, Inc. (Issuer) CIK: 0001692830 (see all company filings)

IRS No.: 813039831 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations